Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Targeting checkpoint inhibitors using monoclonal antibodies results in significantly better outcome of cancer patients compared to conventional chemotherapy. However, the current companion diagnostics to predict response is so far suboptimal, since they base on more or less reliable immunohistochemical approaches. In order to overcome these limitations, we analyzed epigenetic modifications of PDCD1 (PD1), CD274 (PD-L1), and CTLA4 in NSCLC tissues from 39 patients. Results were correlated with transcriptome data. Significant differences in the CpG-methylation patterns between tumor tissues and matched controls were observed for CTLA4 and PDCD1 (PD1) showing a decreased methylation of these genes compared to matched tumor-free tissues from the same patients. Results were confirmed by bisulfide sequencing in an independent validation cohort. Hypomethylation also resulted in increased expression of these genes as shown by transcriptome data. These epigenetic pathways as a hallmark of NSCLC might be useful to generate more precise diagnostic approaches in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, whether the epigenetic landscape of the tumor cells or T cell exhaustion is contributing to resistance is not well understood, leaving much room for further understanding of how epigenetics can lead to nonresponse to ICIs (108, 109).”
From Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance (2021) · cites this paper as [108]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chiappinelli, K. B., Strissel, P. L., Desrichard, A., Li, H., Henke, C., Akman, B., Hein, A., Rote, N. S., Cope, L. M., Snyder, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.011 · Cited by 2,022
Ogino, S., Lochhead, P., Chan, A. T., Nishihara, R., Cho, E., Wolpin, B. M., Meyerhardt, J. A., Meissner, A., Schernhammer, E. S., Fuchs, C. S., et al. (2013) · Modern Pathology · doi:10.1038/modpathol.2012.214 · Cited by 212
Marwitz, S., Depner, S., Dvornikov, D., Merkle, R., Szczygieł, M., Müller‐Decker, K., Lucarelli, P., Wäsch, M., Mairbäurl, H., Rabe, K. F., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1326 · Cited by 102 · cited 1×
“Transcriptome analysis from human tissue samples was conducted as described elsewhere [4].”
Self-citationFriemel, C., Ammerpohl, O., Gutwein, J., Schmutzler, A. G., Caliebe, A., Kautza, M., von Otte, S., Siebert, R., & Bens, S. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.12.054 · Cited by 50 · cited 1×
“described before [3]: cg25798782 (chr2: 242,795,283; forward primer: ttagggagatttaagttagagttag; reverse primer (biotinylated): accacctactcacatccct; sequencing primer: tgtagtggaggttagt), cg08460026 (chr2: 204,732,475; forward primer: atgtgtatatatagaaggtatttgaatag; reverse primer (biotinylated): aatctccacttaattatccaaatc…”
Self-citationGoldmann, T., Kügler, C., Reinmuth, N., Vollmer, E., & Reck, M. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv510 · Cited by 23 · cited 7×
“In order to overcome these limitations, we analyzed epigenetic modifications of PDCD1 (PD1), CD274 (PD-L1), and CTLA4 in NSCLC tissues from 39 patients.”
Self-citationMarwitz, S., Kolarova, J., Reck, M., Reinmuth, N., Kügler, C., Schädlich, I., Haake, A., Zabel, P., Vollmer, E., Siebert, R., et al. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.79 · Cited by 17 · cited 1×
“To investigate epigenetic modifications in tumor tissues and matched controls, DNA methylation analysis of HOPE-fixed tissues using HumanMethylation450 BeadChips was performed as described in detail elsewhere [2].”
Self-citation
Cited by
Bagchi, S., Yuan, R., & Engleman, E. G. (2021) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042020-042741 · Cited by 2,189
Immune checkpoint inhibitors: recent progress and potential biomarkers
Darvin, P., Toor, S. M., Sasidharan Nair, V., & Elkord, E. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0191-1 · Cited by 2,035
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Zhang, H., Dai, Z., Wu, W., Wang, Z., Zhang, N., Zhang, L., Zeng, W.-J., Liu, Z., & Cheng, Q. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01987-7 · Cited by 535
Immune checkpoint therapy in liver cancer
Xu, F., Jin, T., Zhu, Y., & Dai, C. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0777-4 · Cited by 397
“Recently, epigenetic modifications of the key immune checkpoints including PD-1, PD-L1, and CTLA-4 were analyzed in non-small cell lung cancer tissues from 39 patients [51].”
BackgroundEpigenetic modulation of antitumor immunity for improved cancer immunotherapy
Dai, E., Zhu, Z., Wahed, S., Qu, Z., Storkus, W. J., & Guo, Z. S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01464-x · Cited by 328
“Abbreviations AML: Acute myeloid leukemia; APC: Antigen presenting cells; CAR-T cells: Chimeric antigen receptor T cells; CTCL: Cutaneous T cell lymphoma; Epi-drugs: Epigenetic drug; EZH2: Enhancer of zeste homolog 2; DAMPs: Danger-associated molecular patterns; DC: Dendritic cells; DNMT: DNA methyltransferase; DNMTi:…”
Background
Metadata
- Authors
- Marwitz, S., Scheufele, S., Perner, S., Reck, M., Ammerpohl, O., & Goldmann, T.
- Affiliations
- German Center for Lung Research (DE)
- University of Lübeck (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- Corresponding author
- Goldmann, Torsten
- Venue
- Clinical Epigenetics
- Published
- 2017-05-11
- Volume
- 9
- Issue
- 1
- Pages
- 51-51
- ISSN
- 1868-7075 (ISSN-L)
- 1868-7083
- PMC
- PMC5426039
- OpenAlex
- W2613059675
- Cited by
- 68
- References
- 6
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 7 · 2023: 3 · 2022: 14 · 2021: 12 · 2020: 12 · 2019: 5 · 2018: 10
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Clinical Epigenetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Deutsches Zentrum für Lungenforschung (82DZL001A5)
- German Ministry for Education and Research (01EY1103)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- non-small cell lung cancer, CTLA-4, PDCD1, PD-L1, immune checkpoint genes, DNA methylation, CpG methylation, gene hypomethylation, gene expression, immune checkpoint inhibitors, companion diagnostics, tumor tissue
- MeSH terms
- Carcinoma, Non-Small-Cell Lung, Female, Humans, Lung Neoplasms, Male, Cohort Studies, Up-Regulation, Gene Expression Regulation, Neoplastic, Sequence Analysis, RNA, CpG Islands, DNA Methylation, Gene Expression Profiling, Epigenesis, Genetic, CTLA-4 Antigen, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression. https://app.cochat.ai/papers/10.1186/s13148-017-0354-2
- The paper
- Marwitz, S., Scheufele, S., Perner, S., Reck, M., Ammerpohl, O., & Goldmann, T. (2017). Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression. Clinical Epigenetics. https://doi.org/10.1186/s13148-017-0354-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.